DE69010606D1 - 3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik. - Google Patents

3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.

Info

Publication number
DE69010606D1
DE69010606D1 DE69010606T DE69010606T DE69010606D1 DE 69010606 D1 DE69010606 D1 DE 69010606D1 DE 69010606 T DE69010606 T DE 69010606T DE 69010606 T DE69010606 T DE 69010606T DE 69010606 D1 DE69010606 D1 DE 69010606D1
Authority
DE
Germany
Prior art keywords
optionally substituted
alkyl
substituted phenyl
hydrogen
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69010606T
Other languages
English (en)
Other versions
DE69010606T2 (de
Inventor
Mitsuo Nagano
Junichi Sakai
Nobuyoshi Iwata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of DE69010606D1 publication Critical patent/DE69010606D1/de
Application granted granted Critical
Publication of DE69010606T2 publication Critical patent/DE69010606T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69010606T 1989-09-26 1990-09-17 3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik. Expired - Fee Related DE69010606T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24970089 1989-09-26
JP9697690 1990-04-12

Publications (2)

Publication Number Publication Date
DE69010606D1 true DE69010606D1 (de) 1994-08-18
DE69010606T2 DE69010606T2 (de) 1995-03-23

Family

ID=26438116

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69010606T Expired - Fee Related DE69010606T2 (de) 1989-09-26 1990-09-17 3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.

Country Status (8)

Country Link
EP (1) EP0420464B1 (de)
KR (1) KR910006251A (de)
AT (1) ATE108444T1 (de)
CA (1) CA2026177A1 (de)
DE (1) DE69010606T2 (de)
DK (1) DK0420464T3 (de)
ES (1) ES2060056T3 (de)
IE (1) IE69020B1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA879631B (en) * 1986-12-26 1989-08-30 Sankyo Co Centrally-acting muscle relaxants

Also Published As

Publication number Publication date
DE69010606T2 (de) 1995-03-23
DK0420464T3 (da) 1994-11-07
IE903445A1 (en) 1991-04-10
KR910006251A (ko) 1991-04-29
EP0420464A3 (en) 1991-07-17
ATE108444T1 (de) 1994-07-15
ES2060056T3 (es) 1994-11-16
EP0420464A2 (de) 1991-04-03
IE69020B1 (en) 1996-07-24
EP0420464B1 (de) 1994-07-13
CA2026177A1 (en) 1991-03-27

Similar Documents

Publication Publication Date Title
NO873071D0 (no) Fremgangsmaate for fremstilling av amid-derivater.
HUP9902148A2 (hu) Új 2,3-diszubsztituált-4(3H)-kinazolinonok
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE62222T1 (de) Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.
KR910004559A (ko) 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환 아미노)-2-부티닐-1-우레아 및 티오우레아와 그의 유도체
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
DE69018726D1 (de) Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen.
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
DE3750464T2 (de) Pharmazeutisches Präparat zur Behandlung des Katarakts.
DE69010606D1 (de) 3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
ES475977A1 (es) Un procedimiento parala preparacion de derivados de bencil- cicloheptapiridinas
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
KR910700236A (ko) 치환된 3-아자비사이클로[3,1,1]헵탄, 이의 제조방법 및 이의 용도
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE3884878T2 (de) Uricosuretische Zusammensetzung.
FR2633292B1 (fr) Nouveaux derives de la 20,21-dinoreburnamenine substitues en 15 par un groupement amine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les reenfermant
TH11174EX (th) อนุพันธ์ของพิเพอดิลอกซิ-ไอซอกซาโซล,การเตรียมสารเหล่านั้นและการใช้ในการรักษา

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee